Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma

Published:2017-11-07 Issue:4 Volume:48 Page:431-438
ISSN:0941-1291
Container-title:Surgery Today
language:en
Short-container-title:Surg Today

Author:

Takeyama Hideaki,Beppu Toru,Higashi Takaaki,Kaida Takayoshi,Arima Kota,Taki Katsunobu,Imai Katsunori,Nitta Hidetoshi,Hayashi Hiromitsu,Nakagawa Shigeki,Okabe Hirohisa,Hashimoto Daisuke,Chikamoto Akira,Ishiko Takatoshi,Tanaka Motohiko,Sasaki Yutaka,Baba Hideo

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Surgery

Link

http://link.springer.com/article/10.1007/s00595-017-1603-x/fulltext.html

Reference36 articles.

1. Llovet JM, Ricci S, Mazzaferro V, SHARP Investigators Study Group, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378–90.

2. Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia–Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10:25–34.

3. Nakano M, Tanaka M, Kuromatsu R, et al. Efficacy, safety, and survival factors for sorafenib treatment in Japanese patients with advanced hepatocellular carcinoma. Oncology. 2013;84:108–14.

4. Kaneko S, Furuse J, Kudo M, et al. Guideline on the use if new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update. Hepatol Res. 2012;42:523–42.

5. National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology: hepatobiliary cancers. Version Fort Washington, PA: NCCN; 2014.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic conversion therapies for initially unresectable hepatocellular carcinoma: a systematic review and meta-analysis;BMC Cancer;2024-08-14

2. Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects;BioScience Trends;2023-12-31

3. Clinical Features and Outcomes of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma;Cancers;2023-10-30

4. A Case of Giant Hepatocellular Carcinoma Successfully Treated with Lenvatinib Followed by Parenchymal-Sparing Hepatectomy;The Japanese Journal of Gastroenterological Surgery;2023-10-01

5. Surgery for Hepatocellular Carcinoma With Macroscopic Vascular Invasion in the Era of Modern Molecular Therapy;Anticancer Research;2023-09-29